TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Regeneron Pharmaceuticals
Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award

Regeneron's Dupixent was recognized as the 'Best Biotechnology Product' of 2025 by the Galien Foundation, highlighting its groundbreaking approach to treating multiple allergic and inflammatory conditions by targeting IL-4 and IL-13 signaling pathways.

Insights
GOOG   neutral

Briefly mentioned in passing without substantive discussion


REGN   positive

Company received prestigious industry award, demonstrated scientific innovation, and highlighted successful drug development with over 1 million patients treated globally